logo

Press Journals

Intraoperative Neuromonitoring Market to Reach Around $5.5 billion by 2023

February 2017

Global intraoperative neuromonitoring market is forecasted to reach around $5.5 billion by 2023, P&S Market Research.

The growth in the market will be led by the ageing population, increasing prevalence of chronic disorders, applications of IONM in different surgeries, and risk management through IONM during complex surgeries.

Insights on market segments

In terms of product and services, the intraoperative neuromonitoring market has been categorized into systems, instruments, and accessories. The systems segment was the largest contributor to the global market, with more than 45% share in 2016.


On the basis of source type, the intraoperative neuromonitoring industry has been categorized insourced monitoring and outsourced monitoring. The insourced monitoring constituted more than 60% share of the intraoperative neuromonitoring market, globally. However, this share is expected to decrease during the forecast period due to the low maintenance cost associated with outsourced monitoring. Furthermore, the hospital has to provide training and other facilities to its IONM staff on a regular basis, which leads to additional expenses and is a tough task for the hospital.

The global intraoperative neuromonitoring market for brainstem auditory evoked potentials (BAEPs) is expected to witness the fastest growth in demand, registering a CAGR in of around 8% during the forecast period. The other IONM modalities include somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), electromyography (EMG), electroencephalography (EEG), and visual evoked potentials (VEPs).

Explore report with 43 tables and 45 figures spread through 105 pages and detailed TOC on "Intraoperative Neuromonitoring (IONM) Market by Product & Services (Systems, Services, Accessories), by Source Type (Insourced, Outsourced), by Application (Spinal, Neurosurgery, Orthopedic, ENT, Vascular), by Modality (EMG, EEG, MEPs, SSEPs, VEPs, BAEPs), by End User (Hospitals, ASCs), by Geography (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Japan, China, Australia, India, South Korea, Brazil, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2016-2023" at: https://www.psmarketresearch.com/market-analysis/intraoperative-neuromonitoring-market

The IONM applications involve spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. Among the available applications of IONM, orthopedic surgery is estimated to witness the fastest growth in demand at a CAGR of 7.9% during the forecast period. By end user, the intraoperative neuromonitoring market is led by hospitals contributing more than $2 billion in 2016. The large number of hospitals is the major factor to its large share in the market.

Asia-Pacific to exhibit the fastest growth during the forecast period

Asia-Pacific is the potential intraoperative neuromonitoring market for the growth of due to the high population base, presence of unmet medical needs, and increasing disposable incomes of people in the region. Moreover, the medical tourism and technological advancements make Asia-Pacific a lucrative market for IONM. It is estimated that the APAC will witness the fastest growth in demand at a CAGR of 8.6% during the forecast period.

Major players are launching products to enhance their market share

Key players in the intraoperative neuromonitoring industry are launching advanced products, to gain a larger market share. For instance, in February 2016, Nihon Kohden Corporation launched Neuromaster MEE-2000A, an IONM system, used in spine, neurology, vascular orthopedic, and otolaryngologic procedures. Similarly, in October 2016, Modberg Research Inc., launched CNS 300 monitor with wide screen display, high resolution, and advanced ICU amplifier.

Some of the other key players operating in the global intraoperative neuromonitoring market are Accurate Monitoring LLC, Computational Diagnostics, Inc., IntraNerve, LLC, Inomed Medizintechnik GmbH, Medtronic plc, and SpecialtyCare.

GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION

Market Segmentation by Product & Services

  • Systems
  • Accessories
  • Services

Market Segmentation by Source Type

  • Insourced Monitoring
  • Outsourced Monitoring

Intraoperative Neuromonitoring Market Segmentation by Application

  • Spinal Surgery
  • Neurosurgery
  • Vascular Surgery
  • ENT Surgery
  • Orthopedic Surgery
  • Other Surgeries

Market Segmentation by Modality

  • Motor Evoked Potentials (MEPs)
  • Somatosensory Evoked Potentials (SSEPs)
  • Electroencephalography (EEG)
  • Electromyography (EMG)
  • Brainstem Auditory Evoked Potentials (BAEPs)
  • Visual Evoked Potentials (VEPs)

Market Segmentation by End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs)

Market Segmentation by Geography

  • North America intraoperative neuromonitoring market
    • By product & services
    • By source type
    • By application
    • By modality
    • By end user
    • By country – U.S., Canada, Mexico
  • Europe intraoperative neuromonitoring market
    • By product & services
    • By source type
    • By application
    • By modality
    • By end user
    • By country – Germany, France, U.K., Italy, Spain, and Rest of Europe
  • Asia-Pacific intraoperative neuromonitoring market
    • By product & services
    • By source type
    • By application
    • By modality
    • By end user
    • By country – Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific
  • Latin America and Middle East & Africa (LAMEA) intraoperative neuromonitoring market
    • By product & services
    • By source type
    • By application
    • By modality
    • By end user
    • By country – Brazil, Saudi Arabia, South Africa, and Rest of LAMEA